Orbis Research’s Present’s Asia-Pacific Cancer Vaccines Market-Segmented by Type, Technology, End User and Geography (2017-2022) has been prepared based on an in-depth market analysis with inputs from industry experts.
Cancer vaccines are biological preparations that stimulate or strengthen a person's immune system against cancer. Cancer vaccines are usually administered intravenously. They can be used for both adults and children. The vaccines can be broadly classified into prophylactic and therapeutic vaccines. Prophylactic vaccines are used for the prevention of cancer, whereas therapeutic vaccines are used for treatment of the disease. Mordor Intelligence analysts forecast the Asia-Pacific cancer vaccines market to grow at a CAGR of 12-20% over the period (2017 – 2022). The Asia-Pacific market is currently estimated to be valued at USD 209 million as per 2015.
The market for cancer vaccines is much smaller than other cancer therapeutic categories. The size of the market can be attributed to the nascent stages of industry life cycle and the late introduction of the vaccines in the market. To tap this market, many companies from Asia-Pacific are actively investing in cancer vaccine development. The market penetration is expected to increase with the increase in competition among the various pharmaceutical companies to obtain a larger portion of this market.
Get a PDF Sample of Asia-Pacific Cancer Vaccines Market Market Report at: http://www.orbisresearch.com/contacts/request-sample/220369
The Asia-Pacific cancer vaccines market is segmented based on:
Live Attenuated Vaccines
Recombinant Vector Vaccines
Dendritic Cell Vaccines
According to the World Health Organization, 14-million incidences of cancer and 8.2-million cancer deaths were recorded in 2012. Lung, prostate, colorectal, cervical, and breast cancers remain the most common forms of cancer. Thus, there is a rise in demand for vaccines to prevent and treat cancers.
Asia is poised to grow at the highest CAGR during the forecast period, owing to governmental initiatives, rising focus of major players on the Indian vaccine technology market, and increasing immunization initiatives by organizations such as World Health Organization and GAVI in these regions.
Some of the key participants in the industry include Prima BioMed, GlaxoSmithKline, Sanofi S.A, Merck, Aduro BioTech, AstraZeneca plc, OXFORD BIOMEDICA etc.
Increasing cancer cases
Drug innovations with regard to the cancer
Rise in aging populace
Advanced health care services
Upsurge in awareness about cancer and their available therapies in the market
Increasing health care expenditure
Cold chain, or temperature-controlled supply chain, management
Low accessibility to vaccines in remote areas
Stringent regulatory procedures
SPECIALITIES OF THIS REPORT
The report will be useful in gaining an exhaustive understanding of the regional market. It will also be of assistance in providing a comprehensive analysis of the major trends, innovations and associated prospects for market growth over the coming half a decade.
The report will be an ideal source material for industry consultants, manufacturers and other interested and allied parties to gain a critical insight into the factors driving and restraining the market, in addition to opportunities offered.
The report contains wide range of information about the leading market players and the major strategies adopted by them.
Place a Purchase Order for Asia-Pacific Cancer Vaccines Market Report at: http://www.orbisresearch.com/contact/purchase/220369
WHAT THE REPORT OFFERS
Market definition along with identification of key drivers and restraints for the market.
Market analysis with region specific assessments and competition analysis on a global andregional scale.
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
Identification and analysis of the macro and micro factors that affect the industry on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research